Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Receivables - Other (2022 - 2025)

Historic Receivables - Other for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $989936.0.

  • Jin Medical International's Receivables - Other fell 6112.35% to $989936.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $989936.0, marking a year-over-year decrease of 6112.35%. This contributed to the annual value of $989936.0 for FY2025, which is 6112.35% down from last year.
  • As of Q3 2025, Jin Medical International's Receivables - Other stood at $989936.0, which was down 6112.35% from $137550.0 recorded in Q1 2025.
  • Jin Medical International's Receivables - Other's 5-year high stood at $4.9 million during Q1 2023, with a 5-year trough of -$724809.0 in Q3 2023.
  • Moreover, its 4-year median value for Receivables - Other was $137550.0 (2025), whereas its average is $1.1 million.
  • In the last 5 years, Jin Medical International's Receivables - Other tumbled by 65139.94% in 2023 and then surged by 45131.43% in 2024.
  • Jin Medical International's Receivables - Other (Quarter) stood at $131449.0 in 2022, then tumbled by 651.4% to -$724809.0 in 2023, then soared by 451.31% to $2.5 million in 2024, then crashed by 61.12% to $989936.0 in 2025.
  • Its last three reported values are $989936.0 in Q3 2025, $137550.0 for Q1 2025, and $2.5 million during Q3 2024.